Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 3Phase NA 2Phase EARLY_PHASE1 1Phase 4 1Phase 1/2 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Brain Neoplasms 2Glioblastoma 1Central Nervous System Neoplasms 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Craniotomy × Clear all
NCT04690348 2026-06-04

Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
103 enrolled
CNS

Brain Neoplasms

NCT00905060 2021-03-24

HeatShock

University of California, San Francisco

Phase 2 Completed
70 enrolled 12 charts
CNS

Central Nervous System Neoplasms

NCT01413438 2017-07-02

Bevacizumab With or Without Surgery for Adult Glioblastomas

National Institutes of Health Clinical Center (CC)

Phase 2 Withdrawn
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡